Meanwhile, the concentrations of tumor marker carcinoembryonic antigen (CEA) and a soluble fragment of cytokeratin 19 (CYFRA21-1) are significantly lower in the peripheral blood of the experimental group than those of the control group. The gene discussed is CEACAM5; the disease is neoplasm.